Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 220 | 244 | 264 | 209 | 255 |
| Cost of Goods | 107 | 119 | 176 | 101 | 129 |
| Gross Profit | 112 | 125 | 88 | 109 | 126 |
| Operating Expenses | 2,631 | 3,090 | 3,471 | 3,313 | 2,732 |
| Operating Income | -2,411 | -2,846 | -3,207 | -3,104 | -2,477 |
| Interest Expense | 432 | 212 | 203 | 198 | 189 |
| Other Income | -1,782 | 1,266 | 1,712 | -1,414 | -392 |
| Pre-tax Income | -4,625 | -1,793 | -1,698 | -4,716 | -3,057 |
| Net Income Continuous | -4,625 | -1,793 | -1,698 | -4,716 | -3,057 |
| Net Income Discontinuous | -11 | -9 | -13 | -17 | -18 |
| Minority Interests | 15 | 21 | 1 | 15 | 17 |
| Net Income | $-4,650 | $-1,822 | $-1,712 | $-4,748 | $-3,093 |
| EPS Basic Total Ops | -75.01 | -33.75 | -33.75 | -112.51 | -71.26 |
| EPS Basic Continuous Ops | -75.01 | -33.75 | -33.75 | -112.51 | -71.26 |
| EPS Basic Discontinuous Ops | -0.17 | -0.16 | -0.24 | -0.40 | 0.35 |
| EPS Diluted Total Ops | -75.01 | -33.75 | -33.75 | -112.51 | -71.26 |
| EPS Diluted Continuous Ops | -75.01 | -33.75 | -33.75 | -112.51 | -71.26 |
| EPS Diluted Discontinuous Ops | -0.17 | -0.16 | -0.24 | -0.40 | 0.35 |
| EBITDA(a) | $-2,409 | $-2,844 | $-3,205 | $-3,103 | $-2,477 |